This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Jefferies Sticks to Its Buy Rating for Atlas Arteria (MAQAF)

Tipranks - Thu Oct 23, 2025

In a report released today, Anthony Moulder from Jefferies maintained a Buy rating on Atlas Arteria, with a price target of A$5.91. The company’s shares closed last Monday at $2.69.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Moulder covers the Industrials sector, focusing on stocks such as Atlas Arteria, Aurizon Holdings, and Transurban Group. According to TipRanks, Moulder has an average return of 10.2% and a 66.67% success rate on recommended stocks.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Atlas Arteria with a $3.53 average price target.

The company has a one-year high of $4.05 and a one-year low of $2.50. Currently, Atlas Arteria has an average volume of 250.

Based on the recent corporate insider activity of 7 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MAQAF in relation to earlier this year.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.